Clinical trial
Incorporating Supersaturated Oxygen in Shock
NCT04876040 · TherOx, Industry · Withdrawn
Key facts
| NCT number | NCT04876040 |
|---|---|
| Title | Incorporating Supersaturated Oxygen in Shock |
| Official title | A Multi-Center Randomized-Controlled Trial To Evaluate The Safety And Feasibility of The Delivery Of Intracoronary Hyperoxemic Supersaturated Oxygen Therapy For 60 Minutes In Patients With St Elevation Myocardial Infarction (STEMI) And Cardiogenic Shock After Successful Reperfusion (Via PCI) ≤ Six… |
| Acronym | ISO-SHOCK |
| Lead sponsor | TherOx, Industry |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Cardiogenic Shock, STEMI |
| Intervention type | Device, Procedure |
| Interventions | SSO2 Downstream System, PCI + Impella |
| Enrollment | 0 |
| Start date | Dec 17, 2021 |
| Primary completion | Jan 17, 2024 |
| Completion | Jun 1, 2025 |
| First posted | May 6, 2021 |
| Last update posted | Jan 24, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: